AYTU BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.27 USD | +1.87% |
|
+8.64% | +15.14% |
| Feb. 14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 | |
| Feb. 14 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AYTU BIOPHARMA, INC. | Other Pharmaceuticals | +1.87% | +8.64% | +15.14% | +54.25% | -99.26% | 18.21M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- AYTU Stock
- Charts Aytu BioPharma, Inc.
- Comparison Chart